Edwards Lifesciences Stock Performance
as on November 17, 2026 at 2:16 pm IST
Day's Low
Day's High
$104.94$107.95
2.03%
Downside
0.78%
Upside

52 Week's Low
52 Week's High
$74.66$108.00
30.30%
Downside
0.83%
Upside

Edwards Lifesciences share price movements today
- Previous Close
- $107.15
- Open
- $107.15
- Volume
- 2.1M
- Market Cap
- $61.6B
- Day's Low - High
- $104.94 - $107.95
- 52 Week Low - High
- $74.66 - $108.00
Edwards Lifesciences Historical Returns
- 1 Month Return
- + 23.68 %
- 3 Month Return
- + 17.95 %
- 1 Year Return
- + 26.4 %
- 3 Year Return
- + 60.1 %
- 5 Year Return
- -9.5 %
Edwards Lifesciences Stock Fundamentals & Key Indicators
Check Edwards Lifesciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$61.6B
EPS (TTM)
1.77
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.07%
PE Ratio (TTM)
60.54
Industry PE ratio
23.70
PEG Ratio
-2.52
EBITDA
1.6B
Revenue (TTM)
6.7B
Profit Margin
78.13%
Return On Equity TTM
9.69%
Edwards Lifesciences vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Edwards Lifesciences with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $61.6B | -9.50% | 60.54 | 78.13% | 0.00% | |
| Buy | $131.6B | -12.69% | 25.15 | 66.69% | 2.78% | |
| StrongBuy | $188.0B | -16.46% | 40.19 | 57.04% | 2.32% | |
| StrongBuy | $117.9B | 18.57% | 32.77 | 65.52% | 1.14% | |
| Buy | $64.3B | 5.00% | 18.71 | 70.37% | 0.00% |
Stock Returns calculator for Edwards Lifesciences Stock including INR - Dollar returns
The Edwards Lifesciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Edwards Lifesciences investment value today
Current value as on today
₹1,33,937
Returns
₹33,937
(+33.94%)
Returns from Edwards Lifesciences Stock
₹26,398 (+26.4%)
Dollar Impact
₹7,539 (+7.54%)
Analyst Recommendation on Edwards Lifesciences Stock
Based on 16 analysts
93.75%
Buy
6.25%
Hold
0.00%
Sell
Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Edwards Lifesciences. Average target price of $113.39
Edwards Lifesciences Share Price Target
Get share price movements and forecasts by analysts on Edwards Lifesciences.
What analysts predicted
5.54%UPSIDE
Target Price
$113.39
Current Price
$107.11
Analyzed by
16 Analysts
High
$125
Target
$113.39
Low
$97
Edwards Lifesciences target price $113.39, a slight upside of 5.54% compared to current price of $107.11. According to 16 analysts rating.
Indian Investors' Interest in Edwards Lifesciences Stock
Search interest for Edwards Lifesciences Stock has increased by 53% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:53% versus previous 30 day period
Edwards Lifesciences Quarterly Profit & Loss
All numbers in Millions USD
Edwards Lifesciences Annual Profit & Loss
All numbers in Millions USD
Edwards Lifesciences Quarterly Cash Flow
All numbers in Millions USD
Edwards Lifesciences Annual Cash Flow
All numbers in Millions USD
Edwards Lifesciences News & Key Events

Today's Timeline - 05 November
Thu, 05:55 PM
-JPMorgan raises Edwards Lifesciences price target to $120 from $105, maintaining Overweight rating after strong Q3 report.
Thu, 06:06 PM
-Goldman Sachs raises price target on Edwards Lifesciences to $115 from $110, citing earnings beat and guidance raise.
Thu, 06:16 PM
-Edwards Lifesciences reports Q3 earnings of 80 cents, beating estimates, with revenues rising 10.5% year over year.

Today's Timeline - 05 November
Thu, 08:16 PM
-RBC Capital raises price target on Edwards Lifesciences to $115 from $100, maintaining Outperform rating.
Thu, 09:50 PM
-Edwards Lifesciences' 12-month price target raised to $111.04, implying 12% upside, consensus rating remains Buy.
Insights on Edwards Lifesciences
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike

Edwards Lifesciences Corp has shown positive profit trends over the last two quarters. The company's net profit increased from $241.89 million to $307.49 million. This represents an average growth of 21.3% per quarter.
POSITIVE IMPACTBest in 3 Years

In the last 3 years, EW has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACTBest in 1 Year

In the last 1 year, EW has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACTPrice Rise

In the last 1 month, EW stock has moved up by 23.7%
NEGATIVE IMPACTRevenue Fall

Edwards Lifesciences Corp has seen a decline in its revenue for the last two quarters. Revenue dropped from $1.74 billion to $1.71 billion, reflecting an average decrease of 1.5% per quarter.
About Edwards Lifesciences
| Organisation | Edwards Lifesciences |
| Headquarters | One Edwards Way, Irvine, CA, 92614, US |
| Industry | Medical - Devices |
| CEO | Bernard J. Zovighian |
Key Management of Edwards Lifesciences
Name | Title |
|---|---|
Ms. Theodora Mistras | Corporate VP & CFO |
Mr. Joseph Nuzzolese | Corporate Vice President of Global Operations & Quality |
Mr. Andrew M. Dahl | Principal Accounting Officer, Senior VP & Corporate Controller |
Dr. Todd Brinton FACC, M.D. | Corporate VP of Advanced Innovation & Technology and Chief Scientific Officer |
Mr. Bernard J. Zovighian | CEO & Director |
Mr. Donald E. Bobo Jr. | Corporate Vice President of Strategy & Corporate Development |
Ms. Annette Maria Bruls | Corporate Vice President of EMEA, Canada, & Latin America |
Mr. Daveen Chopra | Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies |
Mr. Snehashish Sarkar | Senior VP and Chief Information & Digital Officer |
Mr. Mark D. Peterson | Corporate VP & General Counsel |
FAQs
What is Edwards Lifesciences share price today?
Edwards Lifesciences share price today is $107.11 as on at the close of the market. Edwards Lifesciences share today touched a day high of $107.95 and a low of $104.94.
What is the 52 week high and 52 week low for Edwards Lifesciences share?
Edwards Lifesciences share touched a 52 week high of $108.00 on and a 52 week low of $74.66 on . Edwards Lifesciences stock price today i.e. is closed at $107.11,which is 0.82% down from its 52 week high and 43.46% up from its 52 week low.
What is Edwards Lifesciences's market capitalisation today?
Edwards Lifesciences market capitalisation is $0.06T as on .
How to invest in Edwards Lifesciences Stock (EW) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Edwards Lifesciences on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Edwards Lifesciences Stock (EW) from India?
Indian investors can start investing in Edwards Lifesciences (EW) shares with as little as ₹93.92250061035156 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹939.23 in Edwards Lifesciences stock (as per the Rupee-Dollar exchange rate as on ).
Based on Edwards Lifesciences share’s latest price of $107.11 as on November 17, 2026 at 8:46 am IST, you will get 0.0934 shares of Edwards Lifesciences. Learn more about
fractional shares .
What are the returns that Edwards Lifesciences has given to Indian investors in the last 5 years?
Edwards Lifesciences stock has given -9.5% share price returns and 26.58% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?